287 related articles for article (PubMed ID: 32663175)
1. Bisphenol-A and polycystic ovary syndrome: a review of the literature.
Kechagias KS; Semertzidou A; Athanasiou A; Paraskevaidi M; Kyrgiou M
Rev Environ Health; 2020 Nov; 35(4):323-331. PubMed ID: 32663175
[TBL] [Abstract][Full Text] [Related]
2. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).
Rutkowska A; Rachoń D
Gynecol Endocrinol; 2014 Apr; 30(4):260-5. PubMed ID: 24397396
[TBL] [Abstract][Full Text] [Related]
3. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats.
Yang Z; Shi J; Guo Z; Chen M; Wang C; He C; Zuo Z
Chemosphere; 2019 Sep; 231():151-160. PubMed ID: 31129395
[TBL] [Abstract][Full Text] [Related]
4. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects.
Palioura E; Kandaraki E; Diamanti-Kandarakis E
Horm Mol Biol Clin Investig; 2014 Mar; 17(3):137-44. PubMed ID: 25372737
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome.
Vahedi M; Saeedi A; Poorbaghi SL; Sepehrimanesh M; Fattahi M
Environ Sci Pollut Res Int; 2016 Dec; 23(23):23546-23550. PubMed ID: 27614642
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).
Palioura E; Diamanti-Kandarakis E
Rev Endocr Metab Disord; 2015 Dec; 16(4):365-71. PubMed ID: 26825073
[TBL] [Abstract][Full Text] [Related]
7. Industrial endocrine disruptors and polycystic ovary syndrome.
Palioura E; Diamanti-Kandarakis E
J Endocrinol Invest; 2013 Dec; 36(11):1105-11. PubMed ID: 24445124
[TBL] [Abstract][Full Text] [Related]
8. Bisphenol A and human health: a review of the literature.
Rochester JR
Reprod Toxicol; 2013 Dec; 42():132-55. PubMed ID: 23994667
[TBL] [Abstract][Full Text] [Related]
9. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.
Kandaraki E; Chatzigeorgiou A; Livadas S; Palioura E; Economou F; Koutsilieris M; Palimeri S; Panidis D; Diamanti-Kandarakis E
J Clin Endocrinol Metab; 2011 Mar; 96(3):E480-4. PubMed ID: 21193545
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?
Barrett ES; Sobolewski M
Semin Reprod Med; 2014 May; 32(3):166-76. PubMed ID: 24715511
[TBL] [Abstract][Full Text] [Related]
11. Bisphenol A and polycystic ovary syndrome in human: A systematic review.
Urbanetz LAML; Soares-Junior JM; Dos Santos Simões R; Maciel GAR; Baracat MCP; Baracat EC
Int J Gynaecol Obstet; 2024 Jul; 166(1):190-203. PubMed ID: 38197560
[TBL] [Abstract][Full Text] [Related]
12. Plastic-related endocrine disrupting chemicals significantly related to the increased risk of estrogen-dependent diseases in women.
Chitakwa N; Alqudaimi M; Sultan M; Wu D
Environ Res; 2024 Jul; 252(Pt 2):118966. PubMed ID: 38640992
[TBL] [Abstract][Full Text] [Related]
13. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study.
Vagi SJ; Azziz-Baumgartner E; Sjödin A; Calafat AM; Dumesic D; Gonzalez L; Kato K; Silva MJ; Ye X; Azziz R
BMC Endocr Disord; 2014 Oct; 14():86. PubMed ID: 25348326
[TBL] [Abstract][Full Text] [Related]
14. Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion.
Soave I; Occhiali T; Assorgi C; Marci R; Caserta D
Curr Med Res Opin; 2020 Apr; 36(4):693-703. PubMed ID: 32046531
[No Abstract] [Full Text] [Related]
15. Bisphenol A and the female reproductive tract: an overview of recent laboratory evidence and epidemiological studies.
Caserta D; Di Segni N; Mallozzi M; Giovanale V; Mantovani A; Marci R; Moscarini M
Reprod Biol Endocrinol; 2014 May; 12():37. PubMed ID: 24886252
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome and environmental toxins.
Rutkowska AZ; Diamanti-Kandarakis E
Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
[TBL] [Abstract][Full Text] [Related]
17. Soy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in rats.
Patisaul HB; Mabrey N; Adewale HB; Sullivan AW
Reprod Toxicol; 2014 Nov; 49():209-18. PubMed ID: 25242113
[TBL] [Abstract][Full Text] [Related]
18. Can environmental pollutant bisphenol A increase metabolic risk in polycystic ovary syndrome?
Milanović M; Milošević N; Sudji J; Stojanoski S; Atanacković Krstonošić M; Bjelica A; Milić N; Medić Stojanoska M
Clin Chim Acta; 2020 Aug; 507():257-263. PubMed ID: 32387634
[TBL] [Abstract][Full Text] [Related]
19. Bisphenol A: an endocrine and metabolic disruptor.
Fenichel P; Chevalier N; Brucker-Davis F
Ann Endocrinol (Paris); 2013 Jul; 74(3):211-20. PubMed ID: 23796010
[TBL] [Abstract][Full Text] [Related]
20. The adverse health effects of bisphenol A and related toxicity mechanisms.
Ma Y; Liu H; Wu J; Yuan L; Wang Y; Du X; Wang R; Marwa PW; Petlulu P; Chen X; Zhang H
Environ Res; 2019 Sep; 176():108575. PubMed ID: 31299621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
